Quotes 5-day view Delayed Japan Exchange
01/31/2023
02/01/2023
02/02/2023
02/03/2023
02/06/2023
Date
4158(c)
4153(c)
4115(c)
4087(c)
4120(c)
Last
879 000
687 800
544 900
788 600
765 500
Volume
-0.29%
-0.12%
-0.92%
-0.68%
+0.81%
Change
Estimated financial data (e) JPY USD
Sales 2022
1 698 B
12 967 M
12 967 M
Net income 2022
131 B
1 004 M
1 004 M
Net cash position 2022
323 B
2 468 M
2 468 M
P/E ratio 2022
16,9x
Yield 2022
2,43%
Sales 2023
1 773 B
13 544 M
13 544 M
Net income 2023
163 B
1 245 M
1 245 M
Net cash position 2023
413 B
3 153 M
3 153 M
P/E ratio 2023
13,6x
Yield 2023
2,48%
Capitalization
2 236 B
17 076 M
17 076 M
EV / Sales 2022
1,13x
EV / Sales 2023
1,03x
Nbr of Employees
33 226
Free-Float
65,4%
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale...
Ratings of Otsuka Holdings Co., Ltd.
All news about OTSUKA HOLDINGS CO., LTD.
01/30 Otsuka Pharmaceutical Co., Ltd. Files an Application in Japan for an Additional Indicat.. CI
01/09 IMV Inc. Announces Planned 2023 Milestones to Advance Clinical Development of Lead Ther.. MT
01/08 Lundbeck Wins US FDA's Priority Review Tag For Expanded Use Of Antipsychotic Drug In De.. MT
2022 OTSUKA HOLDINGS CO., LTD. : Ex-dividend day for final dividend FA
2022 Otsuka Group Selected for CDP Climate Change A List AQ
2022 Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Mar.. AQ
2022 Otsuka Medical Devices Co., Ltd. and Recor Medical, Inc. Announce Submission of Applica.. CI
2022 IN BRIEF: Clarify Pharma invests in two "trailblazing" companies AN
2022 ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Th.. BU
2022 Otsuka's Nine-Month Attributable Profit Drops 12% on Higher Expenses, Impairment Loss MT
2022 Otsuka Holdings Co., Ltd. Revises Consolidated earnings Guidance for the Fiscal Year En.. CI
2022 Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending Decembe.. CI
2022 Jefferies Adjusts Otsuka Holding's Price Target to 5,000 Yen From 5,100 Yen, Keeps at H.. MT
2022 KalVista Pharmaceuticals Appoints Brian J.G. Pereira Chairman to Succeed Martin Edwards MT
2022 Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annua.. AQ
News in other languages on OTSUKA HOLDINGS CO., LTD.
Analyst Recommendations on OTSUKA HOLDINGS CO., LTD.
ETFs positioned on OTSUKA HOLDINGS CO., LTD. ETFs and Trackers with Trackinsight
Chart OTSUKA HOLDINGS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends OTSUKA HOLDINGS CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
4 120,00 JPY
Average target price
4 754,55 JPY
Spread / Average Target
15,4%
Please enable JavaScript in your browser's settings to use dynamic charts.